Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...
This page summarizes the latest approvals issued by the U.S. Food and Drug Administration (FDA). The list includes newly approved therapies as well as additional indications for ex...